SCROLL DOWN
Latest news
26. May 2023
SKAN Group AG informs about the ongoing investigation of the Office of the Attorney General of Switzerland
25. May 2023
Statement of SKAN Group AG on an investigation by the Office of the Attorney General of Switzerland
03. May 2023
Annual General Meeting of SKAN Group AG approves all proposals
Next event
22 August
2023
Publication Half-Year Results 2023
26 March
2024
Publication annual results 2023
07 May
2024
Annual General Meeting 2024
Why invest in SKAN?
-
Market Leader
Undisputed market leader globally for high-end aseptic process solutions catering the global biopharma industry
-
Technology and innovation
Technology and innovation leadership with first-to-market solutions and reference point for aseptic manufacturing guidelines
-
Rapidly growing niche market
Strategically positioned in a highly dynamic and rapidly growing niche market driven by strong underlying end market growth
-
Entry barriers
Significant barriers to entry due to regulatory requirements and mission criticality of aseptic processes
-
Blue-chip customer base
Trusted, long-term partner to a large, blue-chip customer base, including all major biopharma companies
-
Excellent financial profile
Excellent financial profile with demonstrated profitable above-market growth and long-term revenue visibility